Ceftriaxone as effective as long-acting chloramphenicol in short-course treatment of meningococcal meningitis during epidemics: a randomised non-inferiority study.
Corty, J F
Alberti, K P
Guerin, P J
AffiliationEpicentre, Paris, France.
MetadataShow full item record
AbstractBACKGROUND: In sub-Saharan Africa in the 1990s, more than 600,000 people had epidemic meningococcal meningitis, of whom 10% died. The current recommended treatment by WHO is short-course long-acting oily chloramphenicol. Continuation of the production of this drug is uncertain, so simple alternatives need to be found. We assessed whether the efficacy of single-dose treatment of ceftriaxone was non-inferior to that of oily chloramphenicol for epidemic meningococcal meningitis. METHODS: In 2003, we undertook a randomised, open-label, non-inferiority trial in nine health-care facilities in Niger. Participants with suspected disease who were older than 2 months were randomly assigned to receive either chloramphenicol or ceftriaxone. Primary outcome was treatment failure (defined as death or clinical failure) at 72 h, measured with intention-to-treat and per-protocol analyses. FINDINGS: Of 510 individuals with suspected disease, 247 received ceftriaxone, 256 received chloramphenicol, and seven were lost to follow-up. The treatment failure rate at 72 h for the intention-to-treat analysis was 9% (22 patients) for both drug groups (risk difference 0.3%, 90% CI -3.8 to 4.5). Case fatality rates and clinical failure rates were equivalent in both treatment groups (14 [6%] ceftriaxone vs 12 [5%] chloramphenicol). Results were also similar for both treatment groups in individuals with confirmed meningitis caused by Neisseria meningitidis. No adverse side-effects were reported. INTERPRETATION: Single-dose ceftriaxone provides an alternative treatment for epidemic meningococcal meningitis--its efficacy, ease of use, and low cost favour its use. National and international health partners should consider ceftriaxone as an alternative first-line treatment to chloramphenicol for epidemic meningococcal meningitis.
- Pre-admission antibiotics for suspected cases of meningococcal disease.
- Authors: Sudarsanam TD, Rupali P, Tharyan P, Abraham OC, Thomas K
- Issue date: 2017 Jun 14
- Meningococcal meningitis epidemic. A new role for single-dose oily chloramphenicol.
- Authors: Hussein AA, Abdel Rahman SI
- Issue date: 2002 Jul
- Bacterial meningitis in children in southern Ghana.
- Authors: Commey JO, Rodrigues OP, Akita FA, Newman M
- Issue date: 1994 Feb
- A field trial of a single intramuscular injection of long-acting chloramphenicol in the treatment of meningococcal meningitis.
- Authors: Puddicombe JB, Wali SS, Greenwood BM
- Issue date: 1984
- Case-fatality ratio of bacterial meningitis in the African meningitis belt: we can do better.
- Authors: Boisier P, Maïnassara HB, Sidikou F, Djibo S, Kairo KK, Chanteau S
- Issue date: 2007 Sep 3